BIO BLAST PHARMA LTD.

Profile

Company Names

BIO BLAST PHARMA LTD.

Addresses

CONNECTICUT FINANCIAL CENTER, 157 CHURCH STREET (19TH FLOOR), NEW HAVEN, CT 06510

35 AHAD HA-AM ST, TEL AVIV, L3 6520206

Phone Numbers

475-655-3032
972 (0) 3 7326616

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2012

State Incorporated:

ISRAEL

Total Amount Raised:

$11,449,999.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2016-03-22 
$6,699,999.00 
$6,699,999.00 
$0.00 
 
1
2014-02-06 
$4,750,000.00 
$4,750,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
MICHAEL 
 
BURSHTINE 
DIRECTOR
BIO BLAST PHARMA LTD.
LEIGH 
 
CHERRY 
EXECUTIVE OFFICER
BIO BLAST PHARMA LTD.
GILI 
 
COHEN 
DIRECTOR
BIO BLAST PHARMA LTD.
ROBERT 
 
COOK 
EXECUTIVE OFFICER
VIGILANT EXPLORATION INC.   |  CNSX MARKETS INC   |  OC MEDICAL HOLDINGS, INC.   |  BIO BLAST PHARMA LTD.   |  FIRST MID BANCSHARES, INC.   |  WYTEC INTERNATIONAL INC
YARON 
 
DANIELY 
DIRECTOR
BIO BLAST PHARMA LTD.
THOMAS 
I. H. 
DUBIN 
DIRECTOR
BIO BLAST PHARMA LTD.
PAUL 
 
FIRUTA 
EXECUTIVE OFFICER
BIO BLAST PHARMA LTD.
COLIN 
 
FOSTER 
EXECUTIVE OFFICER, DIRECTOR
OPTHERION INC   |  BIO BLAST PHARMA LTD.   |  ONCOSYNERGY, INC.   |  ASCENDIA PHARMACEUTICALS, INC.   |  NBO PHARMA INC.
UDI 
 
GILBOA 
DIRECTOR, EXECUTIVE OFFICER
BIO BLAST PHARMA LTD.   |  NASUS PHARMA LTD
MARLENE 
 
HAFFNER 
DIRECTOR
BIO BLAST PHARMA LTD.
ISAAC 
 
KRYMOLOWSKI 
DIRECTOR
BIO BLAST PHARMA LTD.
DALIA 
 
MEGIDDO 
EXECUTIVE OFFICER, DIRECTOR
IMPLIANT INC   |  CHIASMA INC   |  ANGIOSCORE INC.   |  BIO BLAST PHARMA LTD.   |  NASUS PHARMA LTD
RAN 
 
NUSBAUM 
DIRECTOR
BIO BLAST PHARMA LTD.
FREDRIC 
 
PRICE 
DIRECTOR, EXECUTIVE OFFICER
CELSUS THERAPEUTICS PLC.   |  BIO BLAST PHARMA LTD.
THERESA 
M. 
STEVENS 
EXECUTIVE OFFICER
BIO BLAST PHARMA LTD.
WARREN 
 
WASIEWSKI 
EXECUTIVE OFFICER
BIO BLAST PHARMA LTD.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2016-04-01
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
 
2016-03-22 
2014-02-13
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2014-02-06 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
ROTH CAPITAL PARTNERS, LLC
15407
NONE
NONE
H.C. WAINWRIGHT + CO., LLC
375
NONE
NONE
AEGIS CAPITAL CORP.
15007